Vertex Pharmaceuticals Inc. will soon lose a member of its leadership team that helped the company achieve major revenue growth over the past decade.
Financial writer recommends Crispr Therapeutics AG as a strong buy due to cash position, drug pipeline, and promising ...
Google just dropped 4 new Gemini 2.0-series models, with some designed for coding performance and complex prompts and the ...
If you are a Gemini Advanced subscriber, you can access Gemini 2.0 Pro through the model-picker menu on both desktop and ...
NEW YORK, NY / ACCESS Newswire / February 4, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex ...
NEW YORK, NY / ACCESS Newswire / February 5, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex ...
Mistral, the company sometimes considered Europe’s great hope for AI, is releasing several updates to its AI assistant, Le ...
DiaMedica Therapeutics Inc. , a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic diseases, announced today that the Company's management will present ...
Clay Northam Wealth Management LLC increased its stake in Exxon Mobil Co. (NYSE:XOM – Free Report) by 8.4% in the fourth ...
Costello Asset Management INC raised its position in shares of Exxon Mobil Co. (NYSE:XOM – Free Report) by 25.7% in the ...
Google has released a whole new range of AI-powered research and interactions that simply can't be matched by DeepSeek or OpenAI.
App Orchid, a Google Cloud Cortex Framework partner, will enable customers to ask natural language questions and get AI-powered insights from enterprise data grounded with Cortex Framework SAN RAMON, ...